This is the authors' abstract. We don't add key points for this paper.
The prognostication of patients with chronic lymphocytic leukemia (CLL) currently relies on both clinical and biological parameters ([Figure 1][1]). The prime example concerns the TP53 gene, whereby inactivation of TP53 , resulting from either a mutation or chromosome 17p deletion, is associated
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Pospı́šilová et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: